Business Model Breakdown
How Tempus AI Inc Makes Money
TEM
Market Cap
$8.4B
Annual Revenue
$1.1B
Profit Margin
-18.4%
Employees
2,400
The Short Version
Tempus AI Inc. functions as an 'operating system' for precision medicine, utilizing artificial intelligence to analyze vast quantities of clinical and molecular data (including genomics, pathology images, and patient records). They primarily serve healthcare providers by offering advanced diagnostic insights to guide personalized treatment decisions, and pharmaceutical/biotech companies by accelerating drug discovery and clinical trials. Their core value proposition lies in making complex, diverse healthcare data actionable for better patient outcomes and faster therapeutic development.
Where the Revenue Comes From
AI-driven diagnostic testing and analytical services for clinicians (~60-70% estimate)
Data licensing, R&D collaboration, and software subscriptions for pharmaceutical and biotech partners (~30-40% estimate)
Who buys: Oncologists and other specialists, academic medical centers, large healthcare systems, pharmaceutical companies, and biotechnology firms.
Why It Works (Competitive Advantages)
- ✔Proprietary multi-modal data library (clinical, genomic, imaging)
- ✔Advanced AI and machine learning algorithms for data analysis
- ✔Strategic partnerships with leading healthcare institutions and pharma companies
Economic Moat: Narrow (Intangible Assets/IP (Proprietary Data Library, AI Algorithms), Switching Costs (Integration with healthcare systems, pharma pipelines), Network Effects (More data leads to better AI, attracting more users/partners, generating more data))
What Our Analysis Says
DVR Score as of April 10, 2026
Tempus AI Inc. continues to be viewed as a strong contender in the AI-driven precision medicine space. Based on the previous analysis (Q4 2025 earnings), the company demonstrated robust revenue growth (83% YoY) and critically achieved positive adjusted EBITDA, signaling a clear path towards profitability and mitigating a key risk. Strategic partnerships and a proprietary multi-modal data library provide a significant competitive moat within a vast TAM. While current real-time market intelligence did not provide updated financial or news data, the fundamental strengths outlined previously are presumed to hold. The score remains high due to consistency requirements and the absence of any new material information to warrant a significant change. The 10x growth potential remains strong given its strategic positioning.